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Platelet-Mediated Modulation of Adaptive Immunity:
A Communication Link between Innate
and Adaptive Immune Compartments
important consequence of the initial innate inflammatory
response is the stimulation of effective antigen presen-
tation by dendritic cells (DC). Maturation of DC is central
to the development of adaptive immunity to invading
pathogens (Gallucci and Matzinger, 2001), attributed to
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8 Rudolf Virchow Center for Experimental Biomedicine Platelets, upon activation, have been demonstrated
to play a large role in initiation and perpetuation of in-University of Wurzburg
Wurzburg flammatory responses (reviews by Klinger, 1997; Yea-
man, 1997). Recently, platelet expression of CD154 andGermany
other immunomodulatory factors was reported, contrib-
uting to an expanded understanding of platelet function
(Henn et al., 1998, 2001; Ahmad et al., 2001; Diacovo etSummary
al., 1994; Bombeli et al., 1998). It is now clear that ac-
tivated platelets not only function in hemostasis andPlatelets are highly reactive components of the circu-
latory system with well-documented hemostatic func- coagulation but also modulate local inflammatory re-
sponses, including contact sensitivity, inflammatorytion. Recent studies extend platelet function to modu-
lation of local inflammatory events through the release bowel disease, and atherosclerosis through the interac-
tion of platelet-derived immunomodulatory ligands withof chemokines, cytokines, and a number of immuno-
modulatory ligands, including CD154. We hypothe- endothelial cells and infiltrating leukocytes (Henn et al.,
1998, 2001; Ahmad et al., 2001; Diacovo et al., 1994,sized that platelet-derived CD154 modulates adaptive
immunity. The data reported herein demonstrate that 1998; Bombeli et al., 1998; Geba et al., 1996; Collins et
al., 1994; Gawaz et al., 2000; Barry et al., 1998). Given theplatelets, via CD154, induce dendritic cell maturation,
B cell isotype switching, and augment CD8 T cell established importance of CD154 in T and B lymphocyte
immunity, we hypothesized that platelets also performresponses both in vitro and in vivo. Platelet transfusion
studies demonstrate that platelet-derived CD154 a sentinel function, communicating alterations in ho-
meostasis to B and T lymphocyte compartments. Inalone is sufficient to induce isotype switching and aug-
ment T lymphocyte function during viral infection, support of this hypothesis, data reported herein demon-
strate that in vitro activated platelets, through CD154,leading to enhanced protection against viral rechal-
lenge. Additionally, depletion of platelets in normal induce dendritic cell maturation and in vivo enhance
CD8 T cell responses and induce isotype switching.mice results in decreased antigen-specific antibody
production. Moreover, adoptive transfer studies demonstrate that
platelets activated physiologically during adenoviral in-
fection are sufficient, via CD154, for the induction ofIntroduction
isotype switching by B cells and augmentation of the
CD8T cell response during a viral infection that leads toAn innate immune response is often sufficient for patho-
gen clearance. Frequently, however, adaptive immunity enhanced secondary anti-viral immunity. Furthermore,
normal mice depleted of platelets prior to adenovirusmust be initiated to control and resolve infection. The
initial response to a challenge by pathogens is inflamma- injection exhibit decreased efficiency in the production
of adenovirus-specific IgG, underscoring the impor-tion, which involves recruitment and activation of neu-
trophils, monocytes, and macrophages that in turn re- tance of platelets in the generation of an optimal adap-
tive immune response.lease, or provoke, endothelial/epithelial cell release of
cytokines, chemokines, and vasoactive substances that
further enhance inflammation and leukocyte extravasa- Results
tion (Moser and Loetscher, 2001; Lo et al., 1999). An
Activated Murine Platelets Express Functional CD154
Previous studies describing the expression and function*Correspondence: tim-ratliff@uiowa.edu
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Figure 1. Expression of Functional CD154 by Activated Normal B6 Murine Platelets
(A) Platelets from B6 mice were isolated from peripheral blood as described (Clements et al., 1999) and activated with 1 unit/ml thrombin for
10 min. Activated platelets (A-plt) and unactivated platelets (U-Plts) were tested by flow cytometry for the expression of CD154 or CD62P.
(B and C) Effect of activated platelets on IL-6 and IL-12 production by 5 day BMDC (platelets:cells  20:1). Cells were incubated for 24 hr 
activated platelets,  10 g/ml of a blocking anti-CD154 mab (MR-1),  1 g/ml LPS, supernatants harvested, and IL-6 (B) and IL-12 (C)
concentrations determined by ELISA. Activation status of platelets was verified by flow cytometry (data not shown).
(D) Expression of activation markers on BMDC from (B) as measured by flow cytometry.
platelets (Henn et al., 1998, 2001; Ahmad et al., 2001; derived CD154 on primary cells, bone marrow-derived
dendritic cells (BMDC) were generated and incubatedDiacovo et al., 1994; Bombeli et al., 1998; Geba et al.,
1996; Collins et al., 1994; Gawaz et al., 2000; Barry et with syngeneic activated platelets, and production of
IL-6 and IL-12 was measured. The data show that acti-al., 1998). To verify that CD154 is expressed on murine
platelets, unactivated platelets and platelets activated vated platelets induce IL-6 (Figure 1B) and IL-12 (Figure
1C) production by BMDC in a CD154-dependent man-with thrombin (Figure 1A) or collagen (data not shown)
were tested for the surface expression of CD154 or ner. Similarly, activated platelets also induced CD154-
dependent IL-6 production by a murine monocyte cellCD62P (P-selectin), the latter representing a marker for
 granule release in activated human and murine plate- line, RAW 264.7 (data not shown). As previously demon-
strated for CD154 derived from other sources, platelet-lets. The data demonstrate expression of both CD62P
and CD154 on murine activated platelets but not unacti- derived CD154 induced expression of maturation mark-
ers on BMDC (Figure 1D). Expression of B7.1, B7.2, andvated platelets. Further studies demonstrated that sur-
face expression of CD154 persisted on activated plate- ICAM-1 by DC cocultured with activated platelets was
enhanced to a level consistent with LPS-induced matu-lets for up to 8 hr, and that CD154 also was released
into supernatants (data not shown). ration, and platelet-induced enhancement of each was
abrogated by anti-CD154. These data demonstrate thatTo assess the functional capacity of murine platelet-
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murine platelet-derived CD154 is a functional ligand ca- immune response to viral challenge remained to be es-
tablished.pable of inducing CD40-mediated immune function in
in vitro assays.
Biological Relevance of Platelet-Derived CD154 in the
Modulation of Adaptive Immunity to Viral ChallengeSufficiency of Platelet-Derived CD154 to Modulate
Adaptive Immune Responses To address the ability of circulating, unactivated plate-
lets to respond to stimuli in vivo and modulate B andIt is well documented that in mice, injection of adenovi-
rus results in splenic and hepatic inflammation (Zhang T cell responses, a platelet transfusion model was estab-
lished. To allow measurement by flow cytometry, plate-et al., 2001; Jaffee et al., 1992). Thus, since platelets
can modulate inflammation (reviewed by Henn et al., lets were labeled with the fluorescent dye CFSE to as-
sess the effect of the transfer on their activation status1998; Yeaman, 1997) and are able to express CD154,
experiments were initiated to evaluate the potential of and persistence in the circulation. Preliminary in vitro
studies showed that CFSE labeling did not activateplatelets to contribute to adaptive immunity in vivo. Spe-
cifically, transfusion studies were performed to assess platelets and that CFSE-labeled platelets responded to
activation stimuli in a manner identical to unlabeledthe ability of platelet-derived CD154 to induce B lym-
phocyte isotype switching in mice deficient in CD154 platelets (data not shown). Subsequently, CFSE-labeled
platelets (3  108) were transfused into syngeneic hosts(CD154/) (Yang and Wilson, 1996; Renshaw et al.,
1994). The ability of B lymphocytes to switch from the and the recovery of CFSE platelets determined 24 hr
after transfer. The percentage of CFSE platelets mea-production of IgM/IgD to IgG or other Ig isotypes re-
quires CD40 activation (Renshaw et al., 1994). B cell sured in three separate experiments 24 hr after transfer
ranged from 12.5% to 15.6% of the total platelet popula-activation in the absence of CD40 ligation results in
hyper IgM syndrome with minimal switching to IgG se- tion in circulation (Figure 3A). CFSE-labeled platelets
isolated after transfer did not express CD62P, indicatingcretion in humans and mice, making isotype switching
a direct indicator of CD154 function (Renshaw et al., they were unactivated, and reisolated CFSE-labeled
platelets normally expressed CD62P after exposure to1994). Replication-deficient adenovirus type 5 was in-
jected intravenously (iv) into CD154/ mice. Immedi- thrombin in vitro (Figure 3A). These observations dem-
onstrate that platelets can be adoptively transferred inately after adenovirus injection and 24 hr later, activated
platelets from syngeneic normal mice were injected iv, an unactivated state and retain the capacity to be acti-
vated upon exposure to physiological stimuli. Addition-and adenovirus-specific Ig isotypes were measured by
ELISA 9 days after immunization (Figure 2A). The transfer ally, CFSE-labeled platelets were monitored over time
to determine the rate of loss of transferred platelets.of normal activated platelets was sufficient to induce
isotype switching, as shown by IgG1 and IgG2b produc- Consistent with previously reported clearance rates for
murine platelets (Piguet et al., 2001), we found that thetion. Isotype switching was abrogated by anti-CD154,
although adenovirus-specific IgM was efficiently pro- percentage of CFSE-labeled platelets decreases with
time but detectable numbers remain 4 days after transferduced, linking platelet-derived CD154 to the switch to
IgG secretion. Further studies were performed with nor- (Figure 3B).
After the validation of the platelet transfusion system,mal and CD154/ platelets to confirm the sufficiency
of platelet-derived CD154 to induce isotype switching studies were performed to determine whether CD154
derived from platelets activated in response to an ade-(Figure 2B) in CD154/ mice. These data corroborate
the observations in Figure 2A, demonstrating a switch noviral infection was sufficient to induce isotype switch-
ing. Unactivated platelets from normal or CD154/miceto adenovirus-specific IgG in CD154/ mice receiving
activated platelets from normal mice but not those re- were transferred into CD154/ mice, and 24 hr later,
mice were challenged iv with adenovirus. Nine days afterceiving activated platelets from CD154/ mice.
We next determined whether platelet-derived CD154 adenovirus challenge, collected serum was tested for
adenovirus-specific IgG (Figure 4A). The results showmodulated CD8 T cell activation as suggested by its
ability to induce maturation of BMDC in vitro. Activated that switching to IgG occurred in mice receiving nor-
mal platelets, whereas mice receiving platelets fromplatelets from either normal or CD154/ mice were in-
jected subcutaneously (sc) in normal mice adjacent to CD154/mice did not switch to IgG secretion. Adenovi-
rus-specific IgM was produced equally by all groupsthe injection site of adenovirus carrying the gene for
an ovalbumin/transferin receptor fusion protein (Ad5- (data not shown). This platelet CD154-mediated switch-
ing was not due to the action of platelets that may havemOVA) (Kurts et al., 1998; Siemens et al., 2001). Spleen
cells were isolated 10–14 days after immunization and been activated upon injection. CD154/ mice injected
with 108 normal in vitro-activated platelets 24 hr priorthe frequency of ova-specific, IFN-producing CD8
T cells and lytic capacity was determined. The injection to adenovirus injection, which is the time interval sepa-
rating platelet transfusion from adenovirus challenge,of activated platelets from normal, but not CD154/,
mice enhanced the frequency of IFN-producing CD8 did not isotype switch (data not shown). Also, it is un-
likely that injection of infectious adenoviral particles di-T cells (Figure 2C) increasing the total lytic activity (Fig-
ure 2D), which confirms the ability of platelet-derived rectly activates platelets since they are unable to acti-
vate platelets in vitro or induce them to express CD62PCD154 to augment CD8 T cell responses in vivo. Taken
together, these data demonstrate the sufficiency of (Figure 4B). Taken together, these data suggest that
circulating platelets, activated through a normal biologicplatelet-derived CD154 to mediate isotype switching
and enhance CD8 T cell responses; however, the con- response to viral infection, can induce isotype switching
in B lymphocytes through CD154 expression. To estab-tribution of unactivated circulating platelets to an in vivo
Immunity
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Figure 2. Effect of Platelet-Derived CD154 on Isotype Switching and CD8 T Cell Activation In Vivo
(A) Normal B6 mice were injected iv with 108 pfu adenovirus (Ad only), and CD154/ mice were injected iv with either 108 pfu Ad  Tyrode’s
buffer (Ad/Tyrodes), 108 pfu adenovirus  108 activated B6 platelets (Ad/A-Plts), or 108 pfu Ad  108 activated B6 platelets  blocking anti-
CD154 (Ad/A-PltsMR-1). 24 hr later, appropriate groups were injected iv again with 108 activated platelets. 100 g MR-1 was injected into
mice 2 days before and the day of adenovirus immunization. Nine days after adenovirus immunization, serum was collected and assayed for
adenovirus-specific IgG by ELISA (39). The optical density (OD) readings are reported for a serum dilution 1/200 for B6 mice, and 1/40 for
CD154/ mice. IgG OD values for CD154/ naive mice were 	0.051 for all groups. Data are representative of three separate experiments.
(B) CD154/ mice were injected with 108 pfu adenovirus with either Tyrodes buffer (Ad/Tyrodes), activated CD154/ platelets (Ad/KO A-plts),
activated B6 platelets (Ad/B6 A-plts), or 500 g agonistic anti-CD40 ab (Ad/1C10) ip. 24 hr later, appropriate groups were again injected iv
with 108 activated platelets, Tyrodes buffer, or 1C10. OD is reported for a serum dilution of 1/40. The figure is representative of three separate
experiments.
(C) Effect of activated platelets (A-Plts) on ova-specific CD8 T cell frequency. B6 mice were injected sc with 108 B6 (B6 A-plts) or CD154/
(KO A-plts) activated platelets adjacent to the injection site of 108 pfu Ad5-mOVA as described (Siemens et al., 2001). 7–10 days after Ad5-
mOVA immunization, spleens were collected, and spleen cells were isolated and stimulated in vitro for 4 hr with the ovalbumin-expressing
cell line, E.G7, and monitored for intracellular IFN. Numbers in the dot plots indicate the percentage of CD8 T cells that are IFN.
Backgrounds for each mouse were determined by stimulation with EL4, parental cells for E.G7, which lack OVA expression, and were 0.15%
or less for all mice. Data are representative of two separate experiments.
(D) Effect of A-Plts on the lytic capacity of CD154/ CD8 T cells. Splenocytes were isolated as in (C), but were cultured for 5 days with
stimulator E.G7 cells. Viable splenocytes were then harvested and tested as effector cells. Data are representative of three separate experiments.
lish the duration of the platelet CD154-induced switch to and immunized iv with adenovirus. Plasma was col-
lected at weekly intervals and assayed for the presenceIgG, timecourse experiments were performed. CD154/
mice were transfused with CD154/ or normal platelets of adenovirus-specific IgG. Figure 4C demonstrates that
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Figure 3. Characterization of the Activation
Status and Life Span of Normal Unactivated
Platelets after Transfusion into Syngeneic
CD154/ Hosts
(A) CFSE-labeled B6 unactivated platelets
(3  108) were injected iv into normal mice.
Twenty-four hours later, peripheral blood was
collected by tail clipping, and the level of
CFSE-labeled platelets was determined by
flow cytometry. CD62P expression indicated
that adoptively transferred platelets were un-
activated, and retained the ability to be acti-
vated by thrombin in vitro.
(B) Time course of platelet loss was de-
termined by the iv transfusion of 2  108
B6 CFSE-labeled platelets into syngeneic
CD154/ hosts. Platelet loss was monitored
in the peripheral blood of individual mice
(6 mice per group) obtained by daily tail
bleeding. Twenty-four hours after platelet
transfer, 12% of recovered platelets were
CFSE positive, which was established as
100%. Data are representative of three sepa-
rate experiments.
platelet CD154-induced IgG levels peak at day 7 and ble only in the draining lymph node (LN) away from the
sites of platelet clearance. Indeed, Figure 5C demon-return to background by day 28. Consistent with the
short kinetic pattern of IgG expression, GC formation strates that platelet-depleted mice immunized in the
footpad are compromised in their ability to produce IgG.was not observed by histology or flow cytometry (B220
PNA events) (data not shown).
Since data from Figure 4 demonstrate that through Circulating Platelets Are Sufficient to Modulate CD8
T Cell Activity during an Immune ResponseCD154, platelets can induce isotype switching, we pre-
dicted that normal mice depleted of platelets would have Initiated by Virus Infection
Subsequently, studies were performed to determinediminished IgG production in response to antigen chal-
lenge. Using an antibody cocktail (p0p3/4) previously whether platelet activation during a normal antiviral re-
sponse would modulate T cell immunity as observed forshown to clear platelets (Bergmeier et al., 2000), Figure
5A demonstrates normal mice depleted of platelets be- B cells in the isotype switching studies. Platelets from
either normal or CD154/ mice were transferred intofore Ad5-mOVA immunization produce very little adeno-
virus-specific IgG. Additionally, the antibody response CD154/ hosts, and 24 hr later, mice were challenged
iv with Ad5-mOVA. Ten days after Ad5-mOVA challenge,to injection of soluble ova protein after platelet depletion
was measured. Figure 5B demonstrates a reduced abil- spleen cells were isolated, and ova-specific lytic activity
was measured. Consistent with previous reports, ade-ity in these mice to produce ova-specific IgG1 as well.
Upon injection of p0p3/4, platelets are cleared in the novirus induced cytolytic T lymphocyte (CTL) activity in
CD154/ mice (Yang and Wilson, 1996). Mice receivingspleen and liver (data not shown). Although this is
through an Fc-independent mechanism, it is possible CD154/ platelets exhibited enhanced CTL activity,
whereas mice receiving CD154/ platelets show lyticthat isotype switching was inhibited by B cell Fc receptor
binding of platelet-antibody complexes in the spleen, activity equivalent to mice receiving diluent without
platelet transfer (Tyrode’s buffer, Figure 6). These find-although this is unlikely since the mice were able to
produce normal amounts of IgM (data not shown). To ings indicate that platelet-derived CD154 is sufficient
to modulate CD8 T cell responses to an adenovirusaddress this issue, normal mice injected with p0p3/4
were immunized 24 hr later in the footpad with 108 pfu challenge; however, it remained to be established that
these enhanced primary responses resulted in an en-adenovirus to assure isotype switching would be possi-
Immunity
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Figure 4. Ability of Circulating, Unactivated
Normal Platelets Transferred into CD154/
Mice to Induce Isotype Switching in Re-
sponse to Adenovirus Challenge
(A) Unactivated platelets, either CD154/
(Ad/KO Plts) or normal (Ad/B6 Plts), were iso-
lated and transferred (3  108 per recepient)
into CD154/ mice. Twenty-four hours later,
108 pfu adenovirus were injected iv into ap-
propriate groups. Serum was collected for
determination of isotype switching 9 days
after adenovirus challenge. IgG levels were
determined by ELISA as in Figure 2. Data are
representative of two separate experiments.
OD is reported for serum dilutions of 1/200
for normal CD154/ mice, and 1/40 for
CD154/ mice.
(B) Platelets were harvested from B6 mice
and 5 106 were incubated in 1 ml of Tyrodes
buffer  107 pfu adenovirus for 30 min. Posi-
tive control platelets were treated with 0.5
U/ml thrombin for 5 min. CD62P expression
versus CD49b (platelet marker) was mea-
sured by flow cytometry.
(C) To assess duration of platelet-induced
isotype switching, appropriate CD154/
mice were injected with 3  108 normal (KO/
B6 Plts) or CD154/ (KO/KO Plts) platelets
and 24 hr later immunized iv with 2  108 pfu
of adenovirus. Plasma was harvested from
mice at weekly intervals and analyzed as in
Figure 2. Data are representative of two sepa-
rate experiments.
hanced secondary response against adenoviral rechal- of recipients 24 hr after adoptive transfer. We hypothe-
sized that if host platelets were depleted before receiv-lenge.
ing a platelet adoptive transfer, a much greater percent-
age of donor platelets in the circulation could beNormal Platelets Enhance CD154–/– Secondary
Immune Response against Adenovirus attained, further enhancing the ability of the platelets to
modulate the immune response. Initial titrations deter-As stated above, the platelet transfusion model
achieved 12.5%–15.6% donor platelets in the circulation mined the appropriate dose of iv injection of p0p3/4 that
Figure 5. Effect of Platelet Depletion in Nor-
mal Mice on Adenovirus-Specific Antibody
Production
(A) Five B6 mice/group were injected iv with
100 g p0p3/4 (plt-depleted) or not (normal)
on day 0, and 50 g on day 5. Mice were
immunized iv with 108 pfu adenovirus on day
1. Serum was harvested on day 9 and tested
for adenovirus-specific IgG as in Figure 2.
(B) Four-six B6 mice/group were injected iv
with 10 g p0p3/4 (plt-depleted) or not (nor-
mal) on days 0, 3, 6, and 9. Mice were immu-
nized ip with 200 g ovalbumin in PBS on
day 1. Serum was harvested on day 14 and
tested for ova-specific IgG1. Data are repre-
sentative of two experiments.
(C) Five B6 mice/group were injected iv with
100 g p0p3/4 (plt-depleted) or not (normal)
on day 0, and 50 g on day 5. Mice were
immunized sc in the footpad with 108 pfu ade-
novirus on day 1. Serum was harvested on
day 9 and tested for adenovirus-specific IgG
as in Figure 2. Data are representative of two
separate experiments.
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Figure 7. Normal Platelets Enhance Secondary Immune Responses
to Adenovirus in CD154/ Mice
Figure 6. Ability of Circulating Normal Platelets Transferred into CD154/ mice were depleted of endogenous platelets and trans-
CD154/ Mice to Augment CD8 T Cell Activation in Response to fused 24 hr later with normal (KO/B6 Plts) or CD154/ platelets
Adenovirus Challenge (KO/KO Plts). Four hr later, plt-transfused CD154/ and normal
CD154/ mice were injected with Tyrode’s buffer (Tyrodes), normal mice (B6) were immunized iv with 107 pfu of adenovirus. Eleven days
platelets (B6 Plts), or CD154/ platelets (KO Plts), and were immu- later, they were challenged sc on the flank with 2  107 pfu Ad5-
nized iv with 108 pfu Ad5-mOVA 24 hr later. After 10 days, spleno- mOVA. After 10 days, splenocytes were collected for determination
cytes were collected for determination of ova-specific lytic capacity of ova-specific lytic capacity as in Figure 2D. The data are represen-
as in Figure 2D. The data are representative of two separate experi- tative of two separate experiments.
ments.
platelet CD154-mediated response was not due to thedepleted 95%–99% of host platelets but not platelets
action of platelets that may have been activated uponadoptively transferred 24 hr later (data not shown). It
injection. CD154/ mice depleted of endogenous plate-was determined that depletion of host platelets allowed
lets and injected with 108 normal in vitro-activated plate-transfused platelet levels to reach up to 82% of those
lets 4 hr prior to adenovirus injection did not isotypein the circulation 4 hr after transfusion, and up to 45%
switch (data not shown).after 24 hr (data not shown). It is from this platform
that we tested the ability of platelets to contribute to
enhanced viral immunity. Discussion
To determine if the normal platelet-enhanced B and
T cell responses in CD154/ mice resulted in an in- Previously, the main functional role attributed to plate-
lets was hemostasis and maintenance of the integritycreased ability to respond to a secondary viral chal-
lenge, it was necessary to demonstrate that these mice, of the vessel wall. However, more recently it has become
apparent that platelets also play a prominent role inwhen previously immunized with adenovirus, more effi-
ciently eliminated a second adenovirus challenge when modulating inflammation. Upon activation, platelets
release chemokines and cytokines, including IL-8,compared to CD154/ mice transfused with CD154/
platelets. To this end, platelet-depleted CD154/ mice RANTES, MIP-1, MCP-3, cationic proteins, and adhe-
sive proteins, and upon binding to endothelial cells, in-were transfused with either 3  108 normal or CD154/
platelets and primed with 107 pfu of adenovirus. Eleven duce the production of a broad array of inflammatory
molecules including IL-6, IL-8, GM-CSF, and MCP-1days later, they were challenged sc with 2  107 pfu of
Ad5-mOVA (sc injection was necessary to avoid neu- (reviewed by Boehlen and Clemetson, 2001; Klinger,
1997). Platelets also have been reported to express thetralizing IgM in the CD154/ mouse circulation [data
not shown]). After 10 days, ova-specific CTL responses immunomodulatory molecules ICAM-2, CD95L, and
CD154 (Henn et al., 1998; Ahmad et al., 2001; Diacovowere measured. If the normal platelets transfused into
CD154/ mice were able to enhance the initial anti- et al., 1994). In light of the known importance of CD154
in adaptive immunity and the published in vitro studiesadenovirus response, it was predicted that these mice
should have lower ova-specific CTL versus CD154/ demonstrating platelet-derived CD154 activation of en-
dothelial and dendritic cells (Henn et al., 1998; Hilf etmice transfused with CD154/ platelets. As previously
demonstrated, lowered CTL activity would be attribut- al., 2002), we hypothesized that platelet-derived CD154
also modulated adaptive immune responses. Our resultsable to a more efficient secondary immune response to
adenovirus resulting in an inefficient primary response clearly show murine platelet-derived CD154 to be suffi-
cient for the induction of isotype switching and augmen-to ova. (Siemens et al., 2001). Indeed, Figure 7 shows
that platelet-depleted CD154/ mice transfused with tation of primary CD8 T cell responses. Moreover,
platelets appear necessary for optimal IgG production,normal platelets have reduced anti-ova CTL activity as
compared to platelet-depleted CD154/ mice trans- and platelet-derived CD154 is important to the en-
hanced secondary anti-adenoviral immune response,fused with CD154/platelets. This indicates that normal
platelets, through CD154, can contribute to an enhanced suggesting a novel role for platelets in adaptive im-
munity.immune response against a pathogen rechallenge. This
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Initial studies were performed in vitro to verify expres- produce high-affinity IgM shortly after infection are also
those that go on to produce IgG in the GC (Baumgarthsion and function of CD154 in murine platelets, as previ-
ous studies demonstrating expression and function et al., 1999). Additionally, rare GC can be observed as
early as day 3 in an immune response, long before T cellswere performed with human platelets (Henn et al., 1998).
Figure 1 shows expression of CD154 after platelet acti- would be able to provide CD154 stimulation (Szakal et
al., 1990). Although it is well established that CD154vation by either thrombin or collagen as was described
for human platelets. In addition, murine platelet-derived expressed by CD4 T cells is required for GC formation
(reviewed by Parker, 1993), platelets express CD154CD154 was shown to induce the activation/maturation of
DC as measured by increased expression of cell surface within minutes of activation, which could provide the
signal necessary for early GC formation. Our data, whenmarkers and enhanced IL-6 and IL-12 production. These
data are consistent with recent observations demon- combined with these reports, are consistent with a
model in which the naive B cell receptor recognizesstrating human platelet-derived CD154 to upregulate
CD62E, CD54, and CD106 on cultured human umbilical adenoviral repetitive structures and signal 2 is provided
by platelet-expressed CD154 resulting in extrafollicularvein endothelial cells and induce the secretion of MCP-1
and IL-8 (Henn et al., 1998). Likewise, human platelets IgG production. These B cells then begin to form GC
that are subsequently stabilized/matured by antigen-induce maturation of Langerhans cells in in vitro cultures
(Gatti et al., 2000). These data, which uniformly show specific T cells and a mature B cell response ensues.
Without platelets to inititate and T cells to sustain, GCplatelet-mediated activation of CD40 on various cell
types, are contrasted by a recent report demonstrating formation is compromised, consistent with the observa-
tion of a lack of GC in CD154/ mice transfused withthat platelets bind the heat shock protein, gp96, and
attenuate gp96-mediated DC maturation in vitro (Hilf et normal platelets and compromised IgG production in
normal mice depleted of platelets. Conversely, it mayal., 2002). In studies evaluating the effects of platelets
on gp96-induced cytokine production by DC, the au- be that the continual clearance of platelets by the spleen
and liver results in a hindrance of splenic B cell IgGthors did not observe in vitro DC activation by platelets
in the absence of gp96. Based on previous reports and responses; however, this is unlikely since mice continu-
ally depleted of platelets produce normal amounts ofour data demonstrating platelet-mediated DC activa-
tion, the reason for this is unclear, but may involve plate- IgM and inhibition of IgG production also occurs in drain-
ing LN, a site distinct from platelet clearance.let/DC ratios or cell densities in culture. Regardless, our
data, which utilize genetically modified mice to probe In addition to GC dysfunction, T cell responses in
CD154/ mice have been reported to be impaired asplatelet function, extend the observations on platelet
function to the in vivo setting and demonstrate that well. After adenoviral immunization, CD154/ CD4
T cells failed to proliferate or produce cytokines in re-circulating platelets are sufficient to enhance adaptive
T and B cell responses to adenovirus challenge in a sponse to viral antigens (Yang and Wilson, 1996; Yang
et al., 1996). Additionally, CD154/CD8T cell adenovi-CD154-specific manner.
The requirement for CD154 in adaptive T and B lym- rus-specific lytic responses were significantly reduced,
but were restored to near-normal levels by administra-phocyte responses is well established. CD154/CD40 in-
teraction is critical in the generation of thymus-depen- tion of agonistic anti-CD40 monoclonal antibody. Fur-
thermore, CD154/mice had a markedly reduced abilitydent B cell antibody production. Stimulation of naive B
cells through the B cell receptor (signal 1) induces the to eliminate adenoviral transgene (
-galactosidase) ex-
pression in the liver as compared to normal B6 miceproduction of IgM, but CD154-mediated activation of
CD40 by CD4 T cells (signal 2) is necessary for the (Yang and Wilson, 1996). Likewise, in CD154/ mice
LCMV-specific CD8T cell memory responses also wereinitiation of isotype switching (Xu et al., 1994; Renshaw
et al., 1994). Data reported herein show via transfusion impaired (Borrow et al., 1996, 1998). The mechanism for
these deficiencies is uncertain; however, the currentlyof normal platelets into CD154/ mice that platelet-
derived CD154 is sufficient to initiate isotype switching accepted paradigm suggests that optimal CD8 T cell
activation is dependent on CD154-mediated APC matu-to adenoviral antigens in CD154/ mice.
In addition to isotype switching, germinal center for- ration induced by CD4 T cells. The in vivo data pre-
sented herein not only demonstrate the sufficiency ofmation also is dependent on CD40/CD154 signaling. In
germinal centers, B cells undergo somatic hypermuta- platelet-derived CD154 to partially reconstitute isotype
switching but also show platelet-derived CD154 to en-tion, producing antibodies of higher affinity, and differ-
entiate into memory or plasma cells (reviewed by Rudin hance CD8 T cell responses in both normal and
CD154/ mice. Initial studies in which activated plate-and Thompson, 1998). Indeed, CD154/ or CD40/
mice develop a hyper-IgM syndrome, lacking both iso- lets were injected showed augmentation of the fre-
quency of adenovirus-specific T cells and also demon-type switching and germinal center formation, which
can be independent events (Xu et al., 1994; Kawabe et strated enhanced cytotoxic T cell function, suggesting
the sufficiency of platelets for supporting T cell re-al., 1994). Although we have demonstrated that normal
platelets are sufficient to induce isotype switching in sponses. Further studies investigating T cell responses
during adenoviral infection in which circulating normalCD154/ mice, we have not observed the formation of
germinal centers in these mice. Figure 4C demonstrates platelets were transfused into CD154/ mice showed
that platelet-derived CD154 was sufficient to enhancethat the IgG produced in response to platelet CD154 is
transient, consistent with an extrafollicular response. CD8 T cell responses to an adenovirus antigen. The
enhancement of T cell responses is associated withHowever, Figure 5 demonstrates the requirement for
platelets in the generation of robust IgG, presumably increased protection against pathogens and tumors.
Figure 7 demonstrates that only CD154/ mice trans-from GCs. Previous studies suggest that the B cells that
Platelets and Adaptive Immunity
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fused with normal platelets, but not CD154/ mice or mune compartments, transmitting early signals of alter-
those transfused with CD154/ platelets, possess en- ations in homeostasis to B lymphocytes and via DC
hanced secondary immunity against Ad5-mOVA in that maturation to naive T cells.
prior immunity to adenovirus reduces the T cell response Although our data show that activated platelets are
to ova. This enhanced immunity to adenovirus could sufficient to induce DC maturation in vitro, it is unclear
be due to the presence of platelet CD154-induced IgG how they may contribute in vivo in relation to other
(Figures 4A and 4C) at the site of sc injection that neutral- stimuli known to induce DC maturation, including patho-
izes the virus, or to enhanced T cell responses (Figure gen-associated molecular patterns and CpG dinucleo-
6) that eliminate Ad5-mOVA quickly enough to reduce tides and endogenous factors generated by cellular
the primary response to ova, or both. stress and necrotic cell death such as tumor necrosis
The mechanisms by which platelet-derived CD154 factor (TNF) and interleukin 1 (IL-1) (Gallucci and Mat-
communicates with T and B lymphocytes are not known. zinger, 2001). Further studies are necessary to begin to
Data presented herein show that platelet-derived CD154 understand the interrelationships among these factors
provides the necessary second signal for maturing the in the activation of a mature immune response.
antibody response prior to expansion of the helper T cell
Experimental Procedurescompartment, which traditionally provides the CD154
signal and enhances CD8 T cell responses. Since the
Miceiv injection of adenovirus induces splenic inflammation
Normal C57Bl/6 (B6) mice were purchased from the National Cancer
(Zhang et al., 2001), platelet expression of CD154 in the Institute (Frederick, MD). CD154 gene knockout mice (CD154/)
spleen may act locally to induce isotype switching and (B6 background) were purchased from Jackson Laboratories (Bar
induce maturation of splenic DC. Alternatively, during Harbor, ME).
infection or injury, it may be that as resident Langerhans
Reagentscells (LC) migrate through the site, they contact CD154
The intracellular cytokine staining kit, IL-6 and IL-12 ELISA kits, andon activated platelets which initiates/perpetuates their
all flow cytometry antibodies were purchased from PharMingen (Sanmaturation process on the way to the draining lymph
Diego, CA). 5,6-carboxyfluorescein diacetate, succinimidyl ester
node. In support of this concept, activated platelets (CFSE) was purchased from Molecular Probes, Inc. (Eugene, OR).
have been reported to cause maturation of human LC LPS, thrombin, apyrase, PGE1, and mitomycin C were purchased
in vitro (Gatti et al., 2000). Alternatively, soluble CD154 from Sigma (St. Louis, MO). The CD154 blocking antibody MR-1
and agonistic anti-CD40 antibody 1C10 were generous gifts fromand other platelet-derived immunomodulatory ligands
Thomas Waldschmidt (University of Iowa, Iowa City, IA). The plate-(Henn et al., 2001; Ahmad et al., 2001) could be released
let-depleting antibody (a mixture of clones p0p3 and p0p4 (p0p3/4))into the lymph and/or circulatory systems and function
was generated as previously described (Bergmeier et al., 2000). Allat sites distant to the point of platelet activation. The
adenovirus vectors were produced by the Gene Transfer Vector
observations reported herein do not distinguish be- Core at the University of Iowa.
tween these two alternatives; however, in vitro studies
show that platelet-free supernatants from activated Isolation and Activation of Murine Platelets
Murine platelets were isolated essentially as previously describedplatelets induce DC maturation, whereas the platelet
(Clements et al., 1999). In brief, mice were anesthetized and bledpellet has no effect (data not shown). Furthermore, pre-
by cardiac puncture. Blood was collected into syringes containingliminary in vivo studies suggest that platelet-free super-
0.5 ml ACD (12.5 g/L Na Citrate, 10.0 g/L D-glucose, and 6.85 g/Lnatants from activated platelets induce isotype switch-
citric acid), added to 5 ml PIPES (150 mM NaCl and 20 mM PIPES
ing to adenoviral antigens, suggesting the potential for [pH 6.5]), and spun at 100 g for 15 min. The platelet-rich superna-
modulation of adaptive immunity at sites distant from tant was collected and 1 U/ml apyrase and 1 M PGE1 (final concen-
the point of activation through the release of CD154 by trations) were added and spun at 1000  g for 10 min. The platelet
pellet was resuspended in Tyrodes buffer (134 mM NaCl, 2.9 mMactivated platelets. While the findings reported herein
KCL 0.34 mM Na2PO4, 12 mM NaHCO3, 20 mM HEPES, 1 mM MgCl2,clearly demonstrate platelet-mediated modulation of
5 mM glucose, and 0.5 mg/ml BSA [pH to 6.5]), and counted usingadaptive immunity, further studies are needed to deter-
a Coulter Particle Counter (Coulter Corp., Miami, FL). To activatemine whether platelet-derived products function locally
platelets, 0.5 U thrombin/ml was added to platelets in Tyrode’s
or at sites distant to the point of activation and to deter- buffer. All platelet manipulations were performed at room temper-
mine the biological role of platelets during normal im- ature.
mune responses. Also, since the CD154/mice described
Flow Cytometryin this report receive only one platelet transfusion prior
Cells or platelets were incubated with pre-titrated amounts of appro-to the onset of inflammation, it is unknown how the
priate antibodies for 30 min at 4C in the dark, washed 2 in FACScontinued presence of normal platelets from multiple
buffer (2% FCS and 0.02% NaN3 in PBS), and resuspended in 2%transfusions may influence their immune response.
paraformaldehyde. Intracellular IFN was measured according to
That platelets can have a large influence on early in- kit protocol. Events were collected on a FacScan (Beckman, San
nate inflammatory responses is a well-established con- Jose, CA) and analyzed using Cellquest software.
cept (reviewed by Klinger, 1997; Yeaman, 1997). The
data presented herein extend that literature base and Generation and Treatment of BMDC
Bone marrow from B6 mice was harvested from femurs and tibiassuggest a role for platelets in the initiation and/or the
as previously described (Warren et al., 2000). In brief, RBC wereexpression of immunity to invading microorganisms. We
lysed with ACK buffer, B cells were eliminated by panning, andhypothesize that the low activation threshold of platelets
remaining cells were cultured overnight in 24-well plates at 5  105/
allows them to serve a sentinel function, responding to well in complete RPMI (RPMI  FCS, 2-ME, Na Pyruvate, HEPES,
early inflammatory or traumatic events associated with and antibiotics). Nonadherent cells were then collected and cultured
invasion, and that platelet activation forms a communi- for 5 days in 1000 U/ml recombinant murine (rmu) IL-4 (Peprotech,
Rocky Hill, NJ) and rmuGM-CSF (R&D Systems, Minneapolis, MN).cation link via CD154 between innate and adaptive im-
Immunity
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